FDA Approved: CEFDINIR — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for CEFDINIR (cefdinir) submitted by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Otitis Media
• Pharyngitis
• Sinusitis
• Tonsillitis

Drugs mentioned

• Cefdinir (cefdinir)

Snippet

SUPPL AP for CEFDINIR (CEFDINIR)